„sikander“
Suchergebnisse
1.000+ Treffer
-
RFX3 is essential for the generation of functional human pancreatic islets from stem cells
-
Coupling of optimal variation of parameters method with Adomian’s polynomials for nonlinear equations representing fluid flow in different geometries
-
Mother-to-mother therapy in India and Pakistan: adaptation and feasibility evaluation of the peer-delivered Thinking Healthy Programme
-
Flow of carbon nanotubes suspended nanofluid in stretchable non-parallel walls
-
Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD
-
Prevalence of BCL-2/J(H) Translocation in Healthy African Americans
-
Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients
-
Prenatal attachment: using measurement invariance to test the validity of comparisons across eight culturally diverse countries
-
Sublethal necroptosis signaling promotes inflammation and liver cancer
-
Aru gegen die Götter, Band 1: Die Wächter des Himmelspalasts (Rick Riordan Presents)
-
Statistical Optimization of Pectinase Biosynthesis from Orange Peel by Bacillus licheniformis Using Submerged Fermentation
-
Persistent transcriptional changes in cardiac adaptive immune cells following myocardial infarction: New evidence from the re-analysis of publicly available single cell and nuclei RNA-sequencing data sets
-
Die deutsche Exilliteratur 1933 bis 1945 – Perspektiven und Deutungen
-
Aru gegen die Götter, Band 3: Das Geheimnis des Wunschbaums (Rick Riordan Presents)
-
Sikander Singh (Hg.), Wildes Wetter! Wetterbeobachtung, Meteorologie, Klimawandel in der Literatur. Wehrhahn, Hannover 2024. 210 S., € 18, –.
-
Im Reich des Meeresfürsten
-
Sikander gegen die Götter, Band 2: Der Zorn der Drachengöttin (Rick Riordan Presents)
-
Label-free single-cell RNA multiplexing leveraging genetic variability
-
Sikander Singh, Das Glück ist eine Allegorie. Christian Fürchtegott Gellert und die europäische Aufklärung
-
Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis